US 9796974
Modified RNAi agents
granted A61KA61K48/00A61P
Quick answer
US patent 9796974 (Modified RNAi agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K48/00, A61P, A61P31/12, A61P31/18